Table 4. [Treatment of Manifestations in Individuals...]. - GeneReviews®

Manifestation/ Concern	Treatment	Considerations/Other
Clinical bleeding	Local measures
Antifibrinolytic agents; desmopressin	If bleeding is moderate or severe
Platelet transfusion	For acute, moderate-to-severe bleeding ¹
Neoplasm	Standard neoplasm-specific therapy	Consider indications for stem cell transplantation, eligibility, & available donors. Confirm by targeted molecular genetic testing that potential related donors do not have ETV6 thrombocytopenia w/predisposition to leukemia. ²

From: ETV6 Thrombocytopenia and Predisposition to Leukemia

GeneReviews^® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2024.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.